awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48263840-E8080676-CCCD-4B70-9779-C6909FFE306C
Q48263840-E8080676-CCCD-4B70-9779-C6909FFE306C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48263840-E8080676-CCCD-4B70-9779-C6909FFE306C
Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?
P2860
Q48263840-E8080676-CCCD-4B70-9779-C6909FFE306C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48263840-E8080676-CCCD-4B70-9779-C6909FFE306C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82b6647f8d347546e90738905c05581e86f27792
P2860
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update